Evaluating the wearing-off effects of fremanezumab in high-frequency episodic migraine and chronic migraine: A real-world observational study in Japan
Objective: To determine the rate of wearing-off effects of monthly and quarterly dosing of fremanezumab based on real-world data. Methods: We conducted an observational, single-center cohort study including 101 high-frequency episodic migraine or chronic migraine patients receiving fremanezumab over...
Na minha lista:
Principais autores: | Shiho Suzuki (Autor), Keisuke Suzuki (Autor), Tomohiko Shiina (Autor), Yasuo Haruyama (Autor), Koichi Hirata (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
SAGE Publishing,
2023-10-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
por: Keisuke Suzuki, et al.
Publicado em: (2024) -
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine
por: Francesca Schiano di Cola, et al.
Publicado em: (2023) -
Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases
por: Kenta Kashiwagi, et al.
Publicado em: (2023) -
Episodic Mydriasis as Migraine Equivalent
por: J Gordon Millichap
Publicado em: (1991) -
Evaluation of the effect of erenumab on migraine‐specific questionnaire in patients with chronic and episodic migraine
por: Po‐Wei Chen, et al.
Publicado em: (2023)